1,358 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
AstraZeneca's Fasenra Gets FDA Nod for Self-Administration http://www.zacks.com/stock/news/552912/astrazenecas-fasenra-gets-fda-nod-for-self-administration?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-552912 Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study
Puma Biotech Gets FDA Nod of Labeling Supplement for Nerlynx http://www.zacks.com/stock/news/549301/puma-biotech-gets-fda-nod-of-labeling-supplement-for-nerlynx?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-549301 Oct 04, 2019 - The FDA approves the label update of Puma Biotech's (PBYI) breast cancer drug Nerlynx in order to add data from the CONTROL study. Stock gains.
Pharma Stock Roundup: JNJ's Opioid Settlement, FDA Updates for AZN, GSK, MRK, RHHBY http://www.zacks.com/stock/news/549246/pharma-stock-roundup-jnjs-opioid-settlement-fda-updates-for-azn-gsk-mrk-rhhby?cid=CS-ZC-FT-analyst_blog|stock_roundup-549246 Oct 04, 2019 - J&J (JNJ) settles with two Ohio plaintiffs for $10 million. FDA updates for AstraZeneca (AZN), Merck (MRK) and others and ESMO presentations by big pharma companies in focus.
Novartis Reports Additional Data on Spondylitis Drug Cosentyx http://www.zacks.com/stock/news/547460/novartis-reports-additional-data-on-spondylitis-drug-cosentyx?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-547460 Oct 03, 2019 - Novartis (NVS) announces additional positive data from the phase III PREVENT study on spondylitis drug, Cosentyx.
Novartis (NVS) Announces Data on Asthma Drugs & Kisqali http://www.zacks.com/stock/news/545899/novartis-nvs-announces-data-on-asthma-drugs-kisqali?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-545899 Oct 02, 2019 - Novartis (NVS) announces data from late-stage studies on asthma drugs and breast cancer drug, Kisqali.
Novartis AG (NVS) Updates on Kisqali® MONALEESA-3 ESMO Data - Slideshow https://seekingalpha.com/article/4294407-novartis-ag-nvs-updates-kisqali-monaleesaminus-3-esmo-data-slideshow?source=feed_sector_healthcare Oct 01, 2019 - The following slide deck was published by Novartis AG in conjunction with this event.
Roche's (RHHBY) Rituxan Receives FDA Nod for Label Expansion http://www.zacks.com/stock/news/542716/roches-rhhby-rituxan-receives-fda-nod-for-label-expansion?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-542716 Sep 30, 2019 - Roche (RHHBY) gets FDA approval for Rituxan to treat children with two rare blood vessel disorders. The company also extends the offer period to acquire Spark Therapeutics.
AbbVie (ABBV) Gets FDA Nod for Label Expansion of HCV Drug http://www.zacks.com/stock/news/539107/abbvie-abbv-gets-fda-nod-for-label-expansion-of-hcv-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-539107 Sep 27, 2019 - AbbVie (ABBV) gets FDA approval for the label expansion of Mavyret.
Here's Why Sanofi (SNY) is Outperforming Its Industry Of Late http://www.zacks.com/stock/news/537152/heres-why-sanofi-sny-is-outperforming-its-industry-of-late?cid=CS-ZC-FT-analyst_blog|price_surge_/_plunge-537152 Sep 26, 2019 - Sanofi's (SNY) stock is on an upward trajectory this year. Let us have a look at the reasons for the same.
Achillion's Danicopan Gets Breakthrough Therapy Tag for PHN http://www.zacks.com/stock/news/537115/achillions-danicopan-gets-breakthrough-therapy-tag-for-phn?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-537115 Sep 26, 2019 - Achillion's (ACHN) oral factor D inhibitor, danicopan, receives Breakthrough Therapy designation from the FDA as a treatment option for PNH. Shares up.

Pages: 1234567891011...136

<<<Page 6>